Quanterix

Quanterix is a Massachusetts-based medical device firm that develops and distributes products such as diagnostic biomarker and immunoassay analyzers for the healthcare sector.

Business Model:

Revenue: $110M

Employees: 201-500

Detailed Quanterix Information

Geographic Data

Quanterix headquarters map

Address: 900 Middlesex Turnpike

City: Billerica

State: MA

Zip: 01821

Country: US

Financial Info

Stage:

grant

Raised Last:

$0

Raised Total:

$507M

Metrics

1,501,174Website Global Rank

17,145Website Monthly Traffic

Twitter Followers

Description

Quanterix is a Massachusetts-based medical device firm that develops and distributes products such as diagnostic biomarker and immunoassay analyzers for the healthcare sector.

Contact Phone:
+16173019400

Contact Email:

Quanterix went public on 12/6/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/6/2017

IPO Valuation:
$317M

Ticker Symbol:
QTRX

IPO Price:
$15/share

Amount Raised:
$64M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2019 Post-IPO Equity $6.2M
1/2012 Venture Round 1 - IQT
IQT
10/2010 Venture Round $2.5M
8/2008 Series A 3 $15M Flagship Pioneering
Bain Capital Ventures
ARCH Venture Partners
Flagship Pioneering
Bain Capital Ventures
ARCH Venture Partners
11/2012 Series C $0 bioMerieux
bioMerieux
In-Q-Tel
Flagship Pioneering
Bain Capital Ventures
ARCH Venture Partners
bioMerieux
bioMerieux
In-Q-Tel
Flagship Pioneering
Bain Capital Ventures
ARCH Venture Partners
2/2021 Post-IPO Equity $287.5M
10/2019 Post-IPO Equity $49.7M
8/2011 Series B 1 $6M In-Q-Tel
In-Q-Tel
3/2012 Debt Financing $2M
3/2022 Grant - Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
6/2019 Post-IPO Equity $49.7M
3/2016 Series D 7 $46M Hercules Capital
ARCH Venture Partners
ARCH Overage Fund
Tufts University
Bain Capital Ventures
Cormorant Asset Management
Trinitas Capital
ARCH Overage Fund
Cormorant Asset Management
Trinitas Capital
Hercules Capital
ARCH Venture Partners
ARCH Overage Fund
Tufts University
Bain Capital Ventures
Cormorant Asset Management
Trinitas Capital
ARCH Overage Fund
Cormorant Asset Management
Trinitas Capital
8/2020 Post-IPO Equity $97.6M
3/2022 Post-IPO Equity -
8/2017 Series D 1 $8.5M T. Rowe Price
T. Rowe Price
T. Rowe Price
T. Rowe Price
3/2022 Post-IPO Equity - Alzheimer’s Drug Discovery Foundation
Alzheimer’s Drug Discovery Foundation
3/2022 Grant 1 - Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
11/2012 Series C 5 $18.5M bioMerieux
bioMerieux
bioMerieux
bioMerieux
1/2012 Venture Round 1 - IQT
IQT
Announced Date Name Price
6/2019 UmanDiagnostics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research